A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitals.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 20 3 2021
medline: 25 2 2023
entrez: 19 3 2021
Statut: ppublish

Résumé

In the era of widespread resistance, there are 2 time points at which most empiric prescription errors occur among hospitalized adults: (1) upon admission (UA) when treating patients at risk of multidrug-resistant organisms (MDROs) and (2) during hospitalization, when treating patients at risk of extensively drug-resistant organisms (XDROs). These errors adversely influence patient outcomes and the hospital's ecology. Retrospective cohort study, Shamir Medical Center, Israel, 2016. Adult patients (aged >18 years) hospitalized with sepsis. Logistic regressions were used to develop predictive models for (1) MDRO UA and (2) nosocomial XDRO. Their performances on the derivation data sets, and on 7 other validation data sets, were assessed using the area under the receiver operating characteristic curve (ROC AUC). In total, 4,114 patients were included: 2,472 patients with sepsis UA and 1,642 with nosocomial sepsis. The MDRO UA score included 10 parameters, and with a cutoff of ≥22 points, it had an ROC AUC of 0.85. The nosocomial XDRO score included 7 parameters, and with a cutoff of ≥36 points, it had an ROC AUC of 0.87. The range of ROC AUCs for the validation data sets was 0.7-0.88 for the MDRO UA score and was 0.66-0.75 for nosocomial XDRO score. We created a free web calculator (https://assafharofe.azurewebsites.net). A simple electronic calculator could aid with empiric prescription during an encounter with a septic patient. Future implementation studies are needed to evaluate its utility in improving patient outcomes and in reducing overall resistances.

Identifiants

pubmed: 33736724
pii: S0899823X20013720
doi: 10.1017/ice.2020.1372
pmc: PMC8459314
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1082-1089

Références

Antimicrob Agents Chemother. 2014 Jul;58(7):3968-75
pubmed: 24798267
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Clin Microbiol Infect. 2015 Apr;21(4):302-12
pubmed: 25743999
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3127-31
pubmed: 26883694
Open Forum Infect Dis. 2018 May 23;5(6):ofy116
pubmed: 29942821
Am J Infect Control. 2013 Feb;41(2):180-2
pubmed: 22939417
Future Microbiol. 2013 Aug;8(8):979-91
pubmed: 23902145
Int J Infect Dis. 2012 Jan;16(1):e60-6
pubmed: 22104303
Antimicrob Agents Chemother. 2010 Dec;54(12):5099-104
pubmed: 20837757
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
Open Forum Infect Dis. 2016 Dec 20;3(4):ofw232
pubmed: 28018930
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2652-63
pubmed: 26856838
Clin Microbiol Infect. 2001 Apr;7(4):218-26
pubmed: 11422246
Antimicrob Agents Chemother. 2011 Jul;55(7):3485-90
pubmed: 21537020
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312778
Clin Microbiol Infect. 2010 Jun;16(6):747-52
pubmed: 19723135
Antimicrob Agents Chemother. 2010 Nov;54(11):4851-63
pubmed: 20733044
Ann Intern Med. 2002 Nov 19;137(10):791-7
pubmed: 12435215
Clin Infect Dis. 2011 Feb 1;52(3):285-92
pubmed: 21217178
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Clin Infect Dis. 2017 Oct 30;65(10):1607-1614
pubmed: 29020294
Anaesth Intensive Care. 2015 Mar;43(2):175-86
pubmed: 25735682
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Infect Control Hosp Epidemiol. 2018 Oct;39(10):1262-1265
pubmed: 30103833
Ann Clin Microbiol Antimicrob. 2016 Apr 26;15:27
pubmed: 27112143
Sci Rep. 2016 Mar 18;6:22911
pubmed: 26987602
BMC Med. 2014 Mar 06;12:40
pubmed: 24597462
Infect Control Hosp Epidemiol. 2012 Aug;33(8):817-30
pubmed: 22759550
Am J Infect Control. 2012 Oct;40(8):760-5
pubmed: 22285709
Infect Dis Clin North Am. 2016 Dec;30(4):967-997
pubmed: 27660090
Ann Intern Med. 2004 Jan 6;140(1):26-32
pubmed: 14706969
Br Med J (Clin Res Ed). 1985 Aug 17;291(6493):432-4
pubmed: 3926230

Auteurs

Shani Zilberman-Itskovich (S)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nathan Strul (N)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Khalil Chedid (K)

University of Michigan School of Public Health, Ann Arbor, Michigan, United States.

Emily T Martin (ET)

University of Michigan School of Public Health, Ann Arbor, Michigan, United States.

Akram Shorbaje (A)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Itzhak Vitkon-Barkay (I)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Gil Marcus (G)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Leah Michaeli (L)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Mor Broide (M)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Matar Yekutiel (M)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yarden Zohar (Y)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Hadas Razin (H)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Amitai Low (A)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Ariela Strulovici (A)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Boaz Israeli (B)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Gal Geva (G)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

David E Katz (DE)

Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Eli Ben-Chetrit (E)

Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Mutaz Dodin (M)

Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Sorabh Dhar (S)

Detroit Medical Center, Detroit, Michigan, United States.
Wayne State University School of Medicine, Detroit, Michigan, United States.

Leo Milton Parsons (LM)

Detroit Medical Center, Detroit, Michigan, United States.
Wayne State University School of Medicine, Detroit, Michigan, United States.

Abdiel Ramos-Mercado (A)

Detroit Medical Center, Detroit, Michigan, United States.
Wayne State University School of Medicine, Detroit, Michigan, United States.

Keith S Kaye (KS)

University of Michigan Medical School, Ann Arbor, Michigan, United States.

Dror Marchaim (D)

Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH